Differential effect of creatine on oxidatively-injured mitochondrial and nuclear DNA

Biochimica et Biophysica Acta - General Subjects

Volumn 1780, Issue 1, 2008, Pages 16-26

  Guidi, Chiara ^a   Potenza, Lucia ^a   Sestili, Piero ^a   Martinelli, Chiara ^a   Guescini, Michele ^a   Stocchi, Laura ^a   Zeppa, Sabrina ^a   Polidori, Emanuela ^a   Annibalini, Giosuè ^a   Stocchi, Vilberto ^a  

^a UNIVERSITY OF URBINO   (Italy)

Author keywords

Antioxidant; Creatine; Mitochondrial DNA; Nuclear DNA; Oxidative DNA damage

Indexed keywords

CELL NUCLEUS DNA; CREATINE; MITOCHONDRIAL DNA;

ARTICLE; CELL ASSAY; CELL PROTECTION; CONTROLLED STUDY; DATA ANALYSIS; ENDOTHELIUM CELL; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; OXIDATIVE STRESS; PRIORITY JOURNAL; UMBILICAL VEIN;

CELLS, CULTURED; CREATINE; DNA; DNA DAMAGE; DNA, MITOCHONDRIAL; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; HYDROGEN PEROXIDE; OXIDATIVE STRESS; UMBILICAL VEINS;

EID: 36749030624     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.09.018     Document Type: Article

References (81)

1. Walker J.B. Creatine: biosynthesis, regulation, and function. Adv. Enzymol. Relat. Areas Mol. Biol. 50 (1979) 177-242
2. Persky A.M., and Brazeau G.A. Clinical pharmacology of dietary supplement Cr monohydrate. Pharmacol. Rev. 53 (2001) 161-176
3. Earnest C.P., Snell P.G., Rodriguez R., Almada A.L., and Mitchell T.L. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol. Scand. 153 (1995) 207-209
4. Casey A., Constantin-Teodosiu D., Howell S., Hultman E., and Greenhaff P.L. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. Am. J. Physiol. 271 (1996) E31-E37
5. Vandenberghe K., Goris M., Van Hecke P., Van Leemputte M., Vangerven L., and Hespel P. Long-term creatine intake is beneficial to muscle performance during resistance training. J. Appl. Physiol. 83 (1997) 2055-2063
6. Smith S.A., Montain S.J., Matott R.P., Zientara G.P., Jolesz F.A., and Fielding R.A. Creatine supplementation and age influence muscle metabolism during exercise. J. Appl. Physiol. 85 (1998) 1349-1356
7. Volek J.S., Duncan N.D., Mazzetti S.A., Staron R.S., Putukian M., Gomez A.L., Pearson D.R., Fink W.J., and Kraemer W.J. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med. Sci. Sports Exerc. 31 (1999) 1147-1156
8. Balsom P.D., Soderlund K., and Ekblom B. Creatine in humans with special reference to creatine supplementation. Sports Med. 18 (1994) 268-280
9. Mujika I., and Padilla S. Creatine supplementation as an ergogenic aid for sports performance in highly trained athletes: a critical review. Int. J. Sports Med. 18 (1997) 491-496
10. Volek W.K.J. Cr supplementation:its effect on human muscular performance and body composition. J. Strength Cond. Res. 10 (1997) 200-210
11. Juhn M.S., and Tarnopolsky M. Oral creatine supplementation and athletic performance: a critical review. Clin. J. Sport Med. 8 (1998) 286-297
12. Demant T.W., and Rhodes E.C. Effects of creatine supplementation on exercise performance. Sports Med. 28 (1999) 49-60
13. Graham A.S., and Hatton R.C. Creatine: a review of efficacy and safety. J. Am. Pharm. Assoc. (Wash.) 39 (1999) 803-810 (quiz 875-807)
14. Kraemer W.J., and Volek J.S. Creatine supplementation. Its role in human performance. Clin. Sports Med. 18 (1999) 651-666 (ix)
15. Benzi G. Is there a rationale for the use of creatine either as nutritional supplementation or drug administration in humans participating in a sport?. Pharmacol. Res. 41 (2000) 255-264
16. Lawler J.M., Barnes W.S., Wu G., Song W., and Demaree S. Direct antioxidant properties of creatine. Biochem. Biophys. Res. Commun. 290 (2002) 47-52
17. Sestili P., Martinelli C., Bravi G., Piccoli G., Curci R., Battistelli M., Falcieri E., Agostini D., Gioacchini A.M., and Stocchi V. Creatine supplementation affords cytoprotection in oxidatively injured cultured mammalian cells via direct antioxidant activity. Free Radic. Biol. Med. 40 (2006) 837-849
18. Kasparova S., Brezova V., Valko M., Horecky J., Mlynarik V., Liptaj T., Vancova O., Ulicna O., and Dobrota D. Study of the oxidative stress in a rat model of chronic brain hypoperfusion. Neurochem. Int. 46 (2005) 601-611
19. Kasparova S., Dobrota D., Mlynarik V., Pham T.N., Liptaj T., Horecky J., Braunova Z., and Gvozdjakova A. A study of creatine kinase reaction in rat brain under chronic pathological conditions - chronic ischemia and ethanol intoxication. Brain Res. Bull. 53 (2000) 431-435
20. Wyss M., and Schulze A. Health implications of creatine: can oral creatine supplementation protect against neurological and atherosclerotic disease?. Neuroscience 112 (2002) 243-260
21. Pearlman J.P., and Fielding R.A. Creatine monohydrate as a therapeutic aid in muscular dystrophy. Nutr. Rev. 64 (2006) 80-88
22. Wallace D.C. Mitochondrial diseases in man and mouse. Science 283 (1999) 1482-1488
23. DiMauro S., and Schon E.A. Mitochondrial respiratory-chain diseases. N. Engl. J. Med. 348 (2003) 2656-2668
24. Holt I.J., Miller D.H., and Harding A.E. Restriction endonuclease analysis of leukocyte mitochondrial DNA in Leber's optic atrophy. J. Neurol. Neurosurg. Psychiatry 51 (1988) 1075-1077
25. Cao Z., Wanagat J., McKiernan S.H., and Aiken J.M. Mitochondrial DNA deletion mutations are concomitant with ragged red regions of individual, aged muscle fibers: analysis by laser-capture microdissection. Nucleic Acids Res. 29 (2001) 4502-4508
26. Wanrooij S., Luoma P., van Goethem G., van Broeckhoven C., Suomalainen A., and Spelbrink J.N. Twinkle and POLG defects enhance age-dependent accumulation of mutations in the control region of mtDNA. Nucleic Acids Res. 32 (2004) 3053-3064
27. Heerdt B.G., Chen J., Stewart L.R., and Augenlicht L.H. Polymorphisms, but lack of mutations or instability, in the promotor region of the mitochondrial genome in human colonic tumors. Cancer Res. 54 (1994) 3912-3915
28. Burgart L.J., Zheng J., Shu Q., Strickler J.G., and Shibata D. Somatic mitochondrial mutation in gastric cancer. Am. J. Pathol. 147 (1995) 1105-1111
29. Habano W., Nakamura S., and Sugai T. Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene 17 (1998) 1931-1937
30. Habano W., Sugai T., Yoshida T., and Nakamura S. Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int. J. Cancer 83 (1999) 625-629
31. Habano W., Sugai T., Nakamura S.I., Uesugi N., Yoshida T., and Sasou S. Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology 118 (2000) 835-841
32. Polyak K., Li Y., Zhu H., Lengauer C., Willson J.K., Markowitz S.D., Trush M.A., Kinzler K.W., and Vogelstein B. Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. 20 (1998) 291-293
33. Fliss M.S., Usadel H., Caballero O.L., Wu L., Buta M.R., Eleff S.M., Jen J., and Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 287 (2000) 2017-2019
34. Parrella P., Xiao Y., Fliss M., Sanchez-Cespedes M., Mazzarelli P., Rinaldi M., Nicol T., Gabrielson E., Cuomo C., Cohen D., Pandit S., Spencer M., Rabitti C., Fazio V.M., and Sidransky D. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. 61 (2001) 7623-7626
35. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39 (2005) 359-407
36. Cortopassi G.A. A neutral theory predicts multigenic aging and increased concentrations of deleterious mutations on the mitochondrial and Y chromosomes. Free Radic. Biol. Med. 33 (2002) 605-610
37. Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H., Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A., Sanger F., Schreier P.H., Smith A.J., Staden R., and Young I.G. Sequence and organization of the human mitochondrial genome. Nature 290 (1981) 457-465
38. DiMauro S., and Schon E.A. Mitochondrial DNA mutations in human disease. Am. J. Med. Genet. 106 (2001) 18-26
39. Yakes F.M., and Van Houten B. Mitochondrial DNA damage is more extensive and persists longer than nuclear DNA damage in human cells following oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 514-519
40. Bohr V.A. Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radic. Biol. Med. 32 (2002) 804-812
41. Sawyer D.E., and Van Houten B. Repair of DNA damage in mitochondria. Mutat. Res. 434 (1999) 161-176
42. Van Houten V.W.B., and Santos J.H. Role of mitochondrial DNA in toxic response to oxidative stress. DNA Rep. 5 (2006) 145-152
43. Walzel B., Speer O., Zanolla E., Eriksson O., Bernardi P., and Wallimann T. Novel mitochondrial creatine transport activity. Implications for intracellular creatine compartments and bioenergetics. J. Biol. Chem. 277 (2002) 37503-37511
44. Santos J.H., Mandavilli B.S., and Van Houten B. Measuring oxidative mtDNA damage and repair using quantitative PCR. Methods Mol. Biol. 197 (2002) 159-176
45. Ibuki Y., Warashina T., Noro T., and Goto R. Coexposure to benzo[α]pyrene plus ultraviolet A induces 8-oxo-7,8-dihydro-2′-deoxyguanosine formation in human skin fibroblasts: preventive effects of anti-oxidant agents. Environ. Toxicol. Pharmacol. 12 (2002) 37-42
46. Sestili P., Martinelli C., and Stocchi V. The fast halo assay: an improved method to quantify genomic DNA strand breakage at the single-cell level. Mutat. Res. 607 (2006) 205-214
47. Kim K., Kim I.H., Lee K.Y., Rhee S.G., and Stadtman E.R. The isolation and purification of a specific "protector" protein which inhibits enzyme inactivation by a thiol/Fe(III)/O2 mixed-function oxidation system. J. Biol. Chem. 263 (1988) 4704-4711
48. Cooke M.S., Evans M.D., Dizdaroglu M., and Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 17 (2003) 1195-1214
49. Santos J.H., Hunakova L., Chen Y., Bortner C., and Van Houten B. Cell sorting experiments link persistent mitochondrial DNA damage with loss of mitochondrial membrane potential and apoptotic cell death. J. Biol. Chem. 278 (2003) 1728-1734
50. Sikorsky J.A., Primerano D.A., Fenger T.W., and Denvir J. Effect of DNA damage on PCR amplification efficiency with the relative threshold cycle method. Biochem. Biophys. Res. Commun. 323 (2004) 823-830
51. Cao J., Jia L., Zhou H.M., Liu Y., and Zhong L.F. Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol. Sci. 91 (2006) 476-483
52. Guidarelli A., Sestili P., Cossarizza A., Franceschi C., Cattabeni F., and Cantoni O. Evidence for dissimilar mechanisms of enhancement of inorganic and organic hydroperoxide cytotoxicity by l-histidine. J. Pharmacol. Exp. Ther. 275 (1995) 1575-1582
53. Sestili P., Guidarelli A., Dacha M., and Cantoni O. Quercetin prevents DNA single strand breakage and cytotoxicity caused by tert-butylhydroperoxide: free radical scavenging versus iron chelating mechanism. Free Radic. Biol. Med. 25 (1998) 196-200
54. Sestili P., Alfieri R., Carnicelli D., Martinelli C., Barbieri L., Stirpe F., Bonelli M., Petronini P.G., and Brigotti M. Shiga toxin 1 and ricin inhibit the repair of H2O2-induced DNA single strand breaks in cultured mammalian cells. DNA Rep. 4 (2005) 271-277
55. *OH and ROS generating radiomimetic chemicals and gamma-rays: study of plasmid DNA, pMTa4, in vitro. Free Radic. Res. 39 (2005) 499-505
56. Adam W., Hartung J., Okamoto H., Saha-Moller C.R., and Spehar K. N-hydroxy-4-(4-chlorophenyl)thiazole-2(3H)-thione as a photochemical hydroxyl-radical source: photochemistry and oxidative damage of DNA (strand breaks) and 2′-deoxyguanosine (8-oxodG formation). Photochem. Photobiol. 72 (2000) 619-624
57. Godley B.F., Shamsi F.A., Liang F.Q., Jarrett S.G., Davies S., and Boulton M. Blue light induces mitochondrial DNA damage and free radical production in epithelial cells. J. Biol. Chem. 280 (2005) 21061-21066
58. Makrigiorgos G.M., Bump E., Huang C., Baranowska-Kortylewicz J., and Kassis A.I. A fluorimetric method for the detection of copper-mediated hydroxyl free radicals in the immediate proximity of DNA. Free Radic. Biol. Med. 18 (1995) 669-678
59. Banmeyer I., Marchand C., Clippe A., and Knoops B. Human mitochondrial peroxiredoxin 5 protects from mitochondrial DNA damages induced by hydrogen peroxide. FEBS Lett. 579 (2005) 2327-2333
60. Su Y.Y.M., and Yang G. Quantitative measurement of hydroxyl radical induced DNA double-strand breaks and the effect of N-acetyl-l-cysteine. FEBS Lett. 580 (2006) 4136-4142
61. Ballinger S.W., Van Houten B., Jin G.F., Conklin C.A., and Godley B.F. Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. Exp. Eye Res. 68 (1999) 765-772
62. Deng G., Su J.H., Ivins K.J., Van Houten B., and Cotman C.W. Bcl-2 facilitates recovery from DNA damage after oxidative stress. Exp. Neurol. 159 (1999) 309-318
63. Mandavilli B.S., Ali S.F., and Van Houten B. DNA damage in brain mitochondria caused by aging and MPTP treatment. Brain Res. 885 (2000) 45-52
64. Richter C., Park J.W., and Ames B.N. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U. S. A. 85 (1988) 6465-6467
65. Beckman K.B., and Ames B.N. Oxidative decay of DNA. J. Biol. Chem. 272 (1997) 19633-19636
66. Bender A., Koch W., Elstner M., Schombacher Y., Bender J., Moeschl M., Gekeler F., Muller-Myhsok B., Gasser T., Tatsch K., and Klopstock T. Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial. Neurology 67 (2006) 1262-1264
67. Ellis A.C., and Rosenfeld J. The role of creatine in the management of amyotrophic lateral sclerosis and other neurodegenerative disorders. CNS Drugs 18 (2004) 967-980
68. Hersch S.M., Gevorkian S., Marder K., Moskowitz C., Feigin A., Cox M., Como P., Zimmerman C., Lin M., Zhang L., Ulug A.M., Beal M.F., Matson W., Bogdanov M., Ebbel E., Zaleta A., Kaneko Y., Jenkins B., Hevelone N., Zhang H., Yu H., Schoenfeld D., Ferrante R., and Rosas H.D. Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′dG. Neurology 66 (2006) 250-252
69. Cantoni O., Sestili P., Guidarelli A., Palomba L., Brambilla L., and Cattabeni F. Cytotoxic impact of DNA single vs. double strand breaks in oxidatively injured cells. Arch. Toxicol., Suppl. 18 (1996) 223-235
70. Latour I., Demoulin J.B., and Buc-Calderon P. Oxidative DNA damage by t-butyl hydroperoxide causes DNA single strand breaks which is not linked to cell lysis. A mechanistic study in freshly isolated rat hepatocytes. FEBS Lett. 373 (1995) 299-302
71. Melidou M., Riganakos K., and Galaris D. Protection against nuclear DNA damage offered by flavonoids in cells exposed to hydrogen peroxide: the role of iron chelation. Free Radic. Biol. Med. 39 (2005) 1591-1600
72. Sestili P., Diamantini G., Bedini A., Cerioni L., Tommasini I., Tarzia G., and Cantoni O. Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. Biochem. J. 364 (2002) 121-128
73. Hollins D.L., Suliman H.B., Piantadosi C.A., and Carraway M.S. Glutathione regulates susceptibility to oxidant-induced mitochondrial DNA damage in human lymphocytes. Free Radic. Biol. Med. 40 (2006) 1220-1226
74. Jarrett S.G., Cuenco J., and Boulton M. Dietary antioxidants provide differential subcellular protection in epithelial cells. Redox Rep. 11 (2006) 144-152
75. Milano J., and Day B.J. A catalytic antioxidant metalloporphyrin blocks hydrogen peroxide-induced mitochondrial DNA damage. Nucleic Acids Res. 28 (2000) 968-973
76. Pieczenik S.R., and Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp. Mol. Pathol. (2007)
77. Hillebrand U., Hausberg M., Stock C., Shahin V., Nikova D., Riethmuller C., Kliche K., Ludwig T., Schillers H., Schneider S.W., and Oberleithner H. 17beta-estradiol increases volume, apical surface and elasticity of human endothelium mediated by Na+/H+ exchange. Cardiovasc. Res. 69 (2006) 916-924
78. Iliakis G.E., Pantelias G.E., Okayasu R., and Blakely W.F. Induction by H2O2 of DNA and interphase chromosome damage in plateau-phase Chinese hamster ovary cells. Radiat. Res. 131 (1992) 192-203
79. Berneburg M., Gremmel T., Kurten V., Schroeder P., Hertel I., von Mikecz A., Wild S., Chen M., Declercq L., Matsui M., Ruzicka T., and Krutmann J. Creatine supplementation normalizes mutagenesis of mitochondrial DNA as well as functional consequences. J. Invest. Dermatol. 125 (2005) 213-220
80. DiMauro S., Hirano M., and Schon E.A. Approaches to the treatment of mitochondrial diseases. Muscle Nerve 34 (2006) 265-283
81. Bender A., Beckers J., Schneider I., Holter S.M., Haack T., Ruthsatz T., Vogt-Weisenhorn D.M., Becker L., Genius J., Rujescu D., Irmler M., Mijalski T., Mader M., Quintanilla-Martinez L., Fuchs H., Gailus-Durner V., de Angelis M.H., Wurst W., Schmidt J., and Klopstock T. Creatine improves health and survival of mice. Neurobiol Aging (2007)